TAO Synergies TAOX
NASDAQ TAOX
$4.12 +0.11 (+2.74%)
As of: Sep 9, 2026 · 12:29 PM EDT

TAO Synergies (TAOX) Share-based Compensation (2019 - 2026)

TAO Synergies' (TAOX) quarterly Share-based Compensation came in at $241725.0 in Q2 2026, down 58.47% on a YoY basis from $582114.0 in Q2 2025, and up 215.57% quarter-over-quarter from $76600.0 in Q1 2026.

Analysis

TAO Synergies (TAOX) Share-based Compensation (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Share-based Compensation for 8 consecutive years, with $241725.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Share-based Compensation fell 58.47% year-over-year to $241725.0; the trailing twelve-month figure through Jun 2026 stood at $1.1 million (down 43.66% YoY), and the FY2025 full-year result was $1.4 million, down 2.59% from the prior year.
  • Share-based Compensation advanced to $241725.0 in Q2 2026 per TAOX's latest filing, from $76600.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $5.0 million in Q4 2023 and bottomed at -$450503.0 in Q2 2024.
  • Historically, Share-based Compensation has averaged $714730.1 across 5 years, with a median of $489538.5 in 2022.
  • The sharpest annual moves came in 2024 and 2026: Share-based Compensation plunged 234.71% in 2024, then soared 1965.25% in 2026.
  • Over 5 years, Share-based Compensation stood at $1.5 million in 2022, then jumped by 231.24% to $5.0 million in 2023, then tumbled by 71.74% to $1.4 million in 2024, then slumped by 46.5% to $753680.0 in 2025, then plunged by 67.93% to $241725.0 in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $241725.0, $76600.0, and $753680.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Amgen 211.37 Bn 197.38 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 181.12 Bn 177.94 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 132.11 Bn 124.26 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn 243.00 Mn
5 Argenx Se 61.69 Bn 56.50 Bn 1.37 Bn -
6 Moderna 54.62 Bn 49.48 Bn 52.00 Mn 120.00 Mn
7 Alnylam Pharmaceuticals 34.14 Bn 30.84 Bn 992.69 Mn 86.63 Mn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn 77.40 Mn
9 Roivant Sciences 30.09 Bn 30.09 Bn 1.16 Mn 83.34 Mn
10 TAO Synergies 30.79 Mn 30.79 Mn - 241,725.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 241,725.00
Mar 31, 2026 76,600.00
Dec 31, 2025 753,680.00
Sep 30, 2025 53,767.00
Jun 30, 2025 582,114.00
Mar 31, 2025 3,709.00
Dec 31, 2024 1.41 Mn
Sep 30, 2024 3,791.00
Jun 30, 2024 -450,503.00
Mar 31, 2024 468,330.00
Dec 31, 2023 4.98 Mn
Sep 30, 2023 15,064.00
Jun 30, 2023 334,416.00
Mar 31, 2023 644,781.00
Dec 31, 2022 1.50 Mn
Sep 30, 2022 510,747.00
Jun 30, 2022 1.02 Mn
Mar 31, 2022 711,558.00
Dec 31, 2021 1.36 Mn
Sep 30, 2021 1.20 Mn